newsfilter
← Latest News
GlobeNewswire·

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

80% Survival in Nonhuman Primates Observed in a Lethal Challenge Model ATLANTA, GA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing